Desmopressin Nasal Spray, USP, 10 mcg/0.1 mL, 5 mL bottle (50 doses)
Recalled by Apotex Corp.
Class II — moderate
Using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.
Apotex Corp. has recalled Desmopressin Nasal Spray, USP, 10 mcg/0.1 mL, 5 mL bottle (50 doses), according to data published by the U.S. Food and Drug Administration (FDA). The recall was reported on April 22, 2026 and was initiated on April 8, 2026. It is classified as a Class II recall, which means using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.
Below is a plain-English summary of what was recalled, why it was recalled, how to tell whether you have the affected product, and what steps you can take. For the complete and most current details, you can view the FDA record linked further down this page.
What was recalled?
This recall covers Desmopressin Nasal Spray, USP, 10 mcg/0.1 mL, 5 mL bottle (50 doses), with approximately N/A affected. The company behind the recall is Apotex Corp., based in Weston, FL. The FDA describes the product as: “Desmopressin Nasal Spray, USP, 10 mcg/0.1 mL, 5 mL bottle (50 doses), Rx only, Mfg by: Apotek inc., Toronto, Ontario, Canada, M9L 1T9, Mfg for: Apotek Corp., Weston, FL 33326, NDC 60505-0815-0”
Why was Desmopressin Nasal Spray, USP, 10 mcg/0.1 mL, 5 mL bottle (50 doses) recalled?
According to the FDA, the stated reason for the recall is: “Defective container: defect in a batch of bottle caps, specifically involving dislodged or missing cap liners.”
What should you do?
If you think you may have bought Desmopressin Nasal Spray, USP, 10 mcg/0.1 mL, 5 mL bottle (50 doses), compare it against the product description and identifying codes (Lot #: VM4231, Exp 06/30/2027) before using it. This recall is currently listed as ongoing.
The general guidance for a matching product is to stop using it and follow the instructions in the official FDA recall notice, which may include a repair, replacement, refund, or safe disposal. When in doubt, contact Apotex Corp. or your local health authority.
About this recall
This recall was distributed in FL. RecallRadar summarizes recall information from public FDA data to make it easier to understand. We are an independent service and are not affiliated with the FDA or any government agency, so please always refer to the official source for the authoritative record — and note the “last synced” date shown on this page, since recall details can change over time.
Full recall details
- Status
- Ongoing
- Date reported
- April 22, 2026
- Recall started
- April 8, 2026
- Distributed in
- FL
What you can do
Check whether any product you have matches the description and codes above. If it does, stop using it and follow the instructions in the official recall notice. When in doubt, contact the company or your local health authority.
Quick answers
Why was Desmopressin Nasal Spray, USP, 10 mcg/0.1 mL, 5 mL bottle (50 doses) recalled?+
According to the FDA: Defective container: defect in a batch of bottle caps, specifically involving dislodged or missin…
How serious is this recall?+
Class II — moderate. Using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.
What should I do if I have Desmopressin Nasal Spray, USP, 10 mcg/0.1 mL, 5 mL bottle (50 doses)?+
Compare your product against the description and identifying codes on this page. If it matches, stop using it and follow the instructions in the official recall notice — this usually means returning it for a refund or discarding it. When in doubt, contact the company or your local health authority.
Opens the U.S. Food and Drug Administration (FDA) data for this recall.
Recall number: D-0510-2026. Information last synced from the FDA on July 6, 2026.